Cannabis Spray for MS, PLS patients

https://www.sciencedaily.com/releases/2018/12/181213190606.htm

Summary: The findings show for the first time that adults with motor neuron disease taking first-line anti-spasticity drugs who were then treated with an oral spray (nabiximols) containing equal parts delta-9 tetrahydrocannabinol THC and cannabidiol (THC-CBD) experienced less spasticity and pain at 6-week follow-up compared with those given placebo.

 

Leave a Reply

Your email address will not be published.